Concepedia

Peter Stephens

PS

Statistics

Publications

7

Citations

562

H-Index

7

Active since

2014

Affiliations

Newcastle University(Current)

Royal Devon & Exeter NHS Foundation Trust

University Hospitals Bristol NHS Foundation Trust

Sheffield Teaching Hospitals NHS Foundation Trust

University Hospitals Birmingham NHS Foundation Trust

Peter Stephens is an author at Newcastle University specializing in tumor biology, cancer therapeutics, and breast cancer.

Top concepts

Publications per year

2014–2020

7

Publications

7

Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial

Nicholas C. Turner, Belinda Kingston, Lucy Kilburn et al. · The Lancet Oncology · 2020 · 334 citations · Full text

First-in-human study of the PARP/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor

Ruth Plummer, Divyanshu Dua, Nicola Cresti et al. · British Journal of Cancer · 2020 · 73 citations · Full text

Phase 1 dose-escalation study of the PARP inhibitor CEP-9722 as monotherapy or in combination with temozolomide in patients with solid tumors

Ruth Plummer, Peter Stephens, Louiza Aissat-Daudigny et al. · Cancer Chemotherapy and Pharmacology · 2014 · 52 citations · Full text

Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio‐resistance in breast cancer

Nouf H. Alsubhi, Fiona K. Middleton, Tarek M.A. Abdel-Fatah et al. · Molecular Oncology · 2015 · 39 citations · Full text

Does the cancer drugs fund lead to faster uptake of cost-effective drugs? A time-trend analysis comparing England and Wales

Charlotte Chamberlain, Simon M. Collin, Peter Stephens et al. · British Journal of Cancer · 2014 · 29 citations · Full text

1–5 of 7